About This Project
A major dose-limiting toxicity of some chemotherapeutics (like cisplatin) is nephrotoxicity, leading to acute kidney injury (AKI) in 30% of patients. The aim of my project is to develop a mouse model that recapitulates the dosing regimen humans receive in order to develop and test novel renoprotective agents. This is important as there are no therapeutic interventions for cisplatin-induced AKI, and no long-term studies on kidney function have been performed in mice treated with cisplatin.
Browse Other Projects on Experiment
Performance-enhancing substances: How do male black widows use chemical cues to gain a competitive advantage?
For a male black widow spider, life is a series of deadly challenges. He must first make a dangerous...